Jaimiess Kit
Product Images NDC 70700-123

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Jaimiess (NDC 70700-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Jaimiess Barchart

A bar chart depicting the percentage of bleeding and/or spotting and bleeding alone over four cycles in days ranging from 1 to 364. Each cycle shows two data points representing bleeding and bleeding or spotting for durations of at least 7 days and 20 days respectively, with percentages indicated above each bar.*

FDA Label Image

Jaimiess-blistercard (Jaimiess Blister)

An illustrated dosage calendar for JAIMIESS kit, showing 13 weeks of daily oral tablets arranged by day of the week (Sunday through Saturday) in rows. Each row corresponds to one week with circular spaces representing individual tablet doses. Arrows indicate the dosing sequence across each week. The image includes storage instructions for the 91-tablet unit at controlled room temperature.*

FDA Label Image

Jaimiess-carton (Jaimiess Carton)

Packaging label for JAIMIESS, a kit of levonorgestrel and ethinyl estradiol tablets, USP, with strengths of 0.15 mg/0.03 mg and ethinyl estradiol 0.01 mg. The label shows it contains 91 tablets in an extended-cycle tablet dispenser. It is labeled as a human prescription drug by Xiromed, LLC with NDC 70700-123. The packaging includes dosing cycle details and manufacturer information indicating production in Spain.*

FDA Label Image

Jaimiess Effect Estimate

A forest plot chart displaying effect estimates from multiple studies comparing Ever COC vs. Never COC use and Current COC use vs. Never-Use. The studies are listed on the left, with effect estimates and confidence intervals represented by points and horizontal lines across a horizontal axis labeled 'Effect Estimate' ranging from -1.50 to 2.00. Numerical odds ratios, risk ratios, and hazard ratios with confidence intervals are shown in a legend box on the right.*

FDA Label Image

Jaimiess Ethinyl Estradiol

Chemical structure diagram of levonorgestrel, one of the active ingredients in JAIMIESS.*

FDA Label Image

Jaimiess Flowchart

An infographic illustrating pregnancy rates per 100 women in one year in relation to different birth control methods. It categorizes methods from fewer pregnancies (implants, injections, intrauterine devices, sterilization) to more pregnancies (no birth control), listing birth control pills, skin patches, vaginal rings, condoms, diaphragms, and behavioral methods in order of effectiveness.*

FDA Label Image

Jaimiess Levonorgestrel

Chemical structure diagram of the active ingredient levonorgestrel, a steroid hormone used in the JAIMIESS kit by Xiromed, LLC. The image shows the molecular framework featuring multiple ring structures characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.